HHRI News & Press Releases
Hennepin Healthcare takes a pulse of the pandemic
by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…
Read More
New website offers added decision support for kidney and liver transplant candidates searching for a transplant center
Minneapolis, Minn. – Transplant candidates face obstacles in finding a transplant program that transplants patients like them. A new online tool developed by researchers at Hennepin Healthcare Research Institute (HHRI) and the University of Minnesota (UMN) is helping to remove those barriers. The website transplantcentersearch.org allows patients to conduct searches…
Read More
Hennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients
Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…
Read More
Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read More
Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19
Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Hennepin Healthcare is a clinical site…
Read More
Exploratory study identifies key factors associated with time pressure in primary care clinicians
Physicians often feel pressed for time during the standard primary care visit. Recent studies have shown that shorter visits are not only common but also lead to unaddressed health issues and a diminished understanding of patient concerns. Thus, it is critical to understand the relationship between time pressure, worklife factors…
Read More
New online tool helps transplant candidates find center that best matches individual patient’s criteria
A new website developed by researchers at Hennepin Healthcare Research Institute (HHRI) and the University of Minnesota (UMN) is making it easier for organ transplant candidates to choose which transplant center is right for them. The website, transplantcentersearch.org, was developed for candidates seeking kidney, liver, heart and lung transplants. Data…
Read More
HHRI researchers awarded NIH HEAL Initiative funding to tackle the nation’s opioid crisis
The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is an aggressive, trans-agency effort to accelerate scientific solutions to stop the nation’s opioid crisis. Its research focus is on improving prevention and treatment for opioid misuse and addiction and enhancing pain management. HHRI investigators across disciplines are at…
Read More
ASPREE-XT (eXTension) study receives $42.3 million to determine longer-term effects of aspirin on health
The ASPREE-XT (eXTension)* study was recently awarded $42.3 million in funding from the National Institute On Aging of the National Institutes of Health (NIH). The five-year grant enables researchers to study if there are possible long-term health benefits of being on low-dose aspirin. ASPREE-XT is led by the Berman Center…
Read More
Study shows trust is an important attribute to clinician satisfaction; identifies characteristics associated with gender, organizational climate
There is a new emphasis on clinician trust in healthcare organizations, but little data about how to build trust and what favorable outcomes might result from doing so. In a prospective study of data collected as part of a randomized control trial, researchers used a previously validated measure to assess…
Read More
CDRG Awarded United States Renal Data System (USRDS) Federal Contract
The Chronic Disease Research Group (CDRG) of the Hennepin Healthcare Research Institute (HHRI) has been selected to administer the United States Renal Data System (USRDS) federal contract. The USRDS is a national registry that collects, analyzes, and distributes information about chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States. In…
Read More
ASPREE study – A Game Changer in Healthcare
The New England Journal of Medicine named the ASPirin in Reducing Events in the Elderly (ASPREE) study one of the 12 most notable articles in 2018 that had an impact on medicine. Led by Hennepin Healthcare Research Institute investigator Anne M. Murray, MD, MSc, in Minneapolis and John J. McNeil,…
Read More
AAHRPP Awards Hennepin Healthcare Full Reaccreditation
On March 18, 2019 Hennepin Healthcare was notified by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) that it has been awarded full reaccreditation of its research program involving human participants for an additional five-year period. AAHRPP accreditation verifies that an organization follows rigorous standards for ethics,…
Read More
Find a dream or a goal, work towards it and lean on your community to help you
Casey Dorr, PhD, is an investigator at the Hennepin Healthcare Research Institute (HHRI), Assistant Professor of Medicine at the University of Minnesota, and now a student again, working on a Master’s degree in Biostatistics. A member of the Mille Lacs Band of Ojibwe, Dr. Dorr is featured in the February…
Read More
University of Minnesota and Hennepin Healthcare Medical experts restore movement and autonomic function in patients with complete paralysis
Study demonstrates spinal cord stimulation as a treatment for chronic spinal cord injury There are more than 290,000 people estimated to be living in the United States with a spinal cord injury. Previously, it has been shown that it is possible to restore some function to young and healthy patients…
Read More
HHRI investigators’ article is Health Affairs editor’s top pick for 2018
Each year, Health Affairs Editor-in-Chief shares his “top ten” articles that focus on unique data sets, under-reported issues or a particular creative way to examine an issue. A paper by Hennepin Healthcare physician-investigators Kate Vickery, MD, MSc; Tyler Winkelman, MD, MS; and colleagues was named the Editor-in-Chief’s top pick for 2018.…
Read More
Dr. Fred Apple to lecture, conduct research in Spain
Hennepin Healthcare Research Institute (HHRI) investigator Fred Apple, PhD, DABCC, has been invited to be a Visiting Professor and Lecturer at Sant Pau Hospital De La Santa Creu, Universitat Autonoma de Barcelona (Spain) for the first Trimester of 2019. His host will be Jordi Ordonez-Llanos, MD, PhD, Senior Consultant, Hospital…
Read More
Study: Rise in meth and opioid use during pregnancy
Usage rates among moms-to-be have spiked in the past decade, with a disparate boost among pregnant women who live in rural counties. Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in…
Read More
Dr. Marco Pravetoni discusses opioid vaccine research on MPR
An estimated 30,000 people died from opioid overdoses in the U.S. in 2017. With so many people being affected what is being done to treat addiction? Marco Pravetoni, PhD, senior investigator at the Hennepin Healthcare Research Institute and associate professor in the Department of Pharmacology at the University of Minnesota…
Read More
Amphetamine-related hospitalizations surge between 2003 and 2015
An analysis conducted by Hennepin Healthcare, University of Minnesota School of Public Health and University of Michigan researchers shows amphetamine-related hospitalizations increased more than 270 percent from 2008 to 2015, costing up to $2.17 billion per year. The study was recently published in JAMA Network Open. “It’s worrying,” said Associate Professor and co-author Nathan Shippee.…
Read More- « Previous
- 1
- 2
- 3
- 4
- Next »